CITALOPRAM
- Product NDC
- 59651-964
- 11-digit product format
- 596510964
- Labeler code
- 59651
- Product ID
- 59651-964_80af8ae8-c106-4895-bab3-0579b41f1e75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CITALOPRAM
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA219985
- Marketing category
- ANDA
- Marketing start
- 2026-03-13
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CITALOPRAM
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CITALOPRAM HYDROBROMIDE | 30 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I1E9D14F36 |
| Rxcui | 2591786 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-964-30 | CITALOPRAM | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-964-30 | 59651096430 | 30 CAPSULE in 1 BOTTLE (59651-964-30) | 30 capsule | 2026-03-13 | No | No | Current |